Figure 25
Peptides most commonly discussed for building muscle in research settings typically target growth hormone signaling pathways
Although AOD-9604 failed in the clinic, it remained popular in the research community around metabolic peptides
THE LANDMARK TRIAL PENN STATE, 6 MONTHS, PEER-REVIEWED: A 6-month randomized, double-blind, placebo-controlled human trial of 54 adults at Penn State University (Richie et al., European Journal of Nutrition, 2015) found that oral Setria L-Glutathione at 250 mg/day produced significant increases in whole-blood glutathione levels at 1, 3, and 6 months versus baseline establishing for the first time that oral glutathione is bioavailable in humans
Phytomedicine 18(23):134142 Lee SY, Lee KS, Yi SH, Kook SH, Lee JC (2013) Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-kappaB pathway and attenuating ROS production